Group Photo

The “International Precision Regenerative Medicine Symposium 2025” was successfully held on December 18, 2025, at the N101 Hall at Macau University of Science and Technology (MUST). The symposium was conducted in a hybrid format, combining on-site and online participation, and brought together leading experts in regenerative medicine, stem cell research, and translational innovation..

Distinguished officiating guests attending the event included: Dr. Vincent U Sang U, President of the Administrative Committee of the Science and Technology Development Fund (FDCT), Macau SAR Government, Ms. Sio Wa TAM, Head of the Division of Tertiary Educational Cooperation and Exchange, Education and Youth Development Bureau, Macau SAR Government, Ms. Gloria Chak, Manager of Convention and Exhibition Industry Development Division of Macao Commerce and Investment Promotion Institute, Dr. Peng Bin LI, Director of Kiang Wu Hospital, Dr. Ka Kuen YUNG, Director of Macau YinKui Hospital, Dr. Wai Seng LEI, Vice President of Macao Medical Center of Islands Healthcare Complex – Macao Medical Center of Peking Union Medical College Hospital, Dr. Wai I NG, Vice President of Kiang Wu Nursing College.

Senior representatives from MUST included: Chair Professor Paul Kwong-Hang TAM, Vice President, and Director of MUST Precision Regenerative Medicine Centre (PRMRC), Chair Professor ZHU Yi Zhun, Associate Vice President and Director of School of Pharmacy, Professor Manson Fok, President of University Hospital and Dean of Faculty of Medicine, and Professor Aliana LEONG Man Wai, Associate Vice President and Dean of the School of Liberal Arts.

Vice President Paul Kwong-Hang TAM delivered remarks

In his welcoming remarks, Vice President Paul Kwong-Hang Tam highlighted that since its establishment in 2023, PRMRC has aimed to build a focused and collaborative platform advancing stem cell biology, regenerative medicine, and translational innovation. He emphasized the Centre’s commitment to maintaining strong links between basic science, clinical research, and industry, as well as nurturing the next generation of scientists and clinicians. He noted that the symposium featured three key themes: Precision and Regenerative Hepatobiliary Medicine, Developmental and Genetic Foundations of Regeneration, and Translational Frontiers in Regenerative Medicine.

President Vincent U Sang U delivered remarks

Dr. Vincent U Sang U highlighted the importance of what he described as the “three Cs” of scientific advancement: connection, curiosity, and collaboration. He encouraged participants to make full use of the symposium as a platform to strengthen professional networks and to initiate new partnerships across disciplines and sectors. Dr. U also outlined the Macau SAR Government’s strategic plans to establish a technology research industrial park, with biomedicine identified as a key priority area, to further support the translation of scientific research into innovation and industrial development. In addition, he noted that Macau is deepening its integration with the Greater Bay Area, with more than 30 Guangdong–Hong Kong–Macau joint laboratories established in recent years, creating new opportunities for cross-regional collaboration in medical sciences and other research fields.

Opening Ceremony Photo

The symposium featured 11 internationally renowned speakers. The programme covered cutting-edge basic research, clinical advances, and industrial translation in precision regenerative medicine, promoting academic exchange and collaboration at local, national, and international levels. Invited speakers included Professor Paolo De Coppi of UCL Great Ormond Street Institute of Child Health, Professor Richard Thompson of King’s College London, Professor Fotios Sampaziotis of University of Cambridge, Professor Huck-Hui Ng of Genome Institute of Singapore, Professor Kathryn Song Eng Cheah of University of Hong Kong, Professor Xuejun Wen of Virginia Commonwealth University, Mr. Luo Yun of Zhongsheng Group, Associate Professor Toan Thang Phan of National University of Singapore, Professor Cheng-Lung Lin of Pell Biotech, Taiwan, Dr. Feng Liu of Benethera Biotechnology, Beijing, and Dr. Li Chen of Likang Life Sciences.

Panel discussions

At the panel discussion session, industry representatives shared cutting-edge research findings, clinical insights, and translational perspectives, contributing to in-depth discussions and panel exchanges that highlighted the future directions of precision regenerative medicine. Before the conclusion of the symposium, Ms. Irene Kan, Functional Head of the Investment Promotion Division of the Commerce and Investment Promotion Institute (IPIM) of the Macau SAR Government, delivered a presentation entitled “Policy Empowerment: The Business Advantages and Opportunities in Macao’s Health Industry.” In her talk, Ms. Kan outlined Macao’s strategic positioning and policy incentives for the development of the health and biomedical sectors, highlighting opportunities for investment, industry–academia collaboration, and technology translation. She emphasized how Macao’s business environment, regulatory framework, and regional connectivity provide a supportive platform for companies and research institutions seeking to establish or expand health-related initiatives in the region.